Related Experiment Video
Updated: Jul 3, 2026
Isolation, Transfection, and Culture of Primary Human Monocytes
Published on: December 16, 2019
A critical role for CD63 in HIV replication and infection of macrophages and cell lines
Hui Chen1, Natallia Dziuba, Brian Friedrich
1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-0435, USA.
Abstract:
HIV infection typically involves interaction of Env with CD4 and a chemokine coreceptor, either CCR5 or CXCR4. Other cellular factors supporting HIV replication have also been characterized. We previously demonstrated a role for CD63 in early HIV infection events in macrophages via inhibition by anti-CD63 antibody pretreatment. To confirm the requirement for CD63 in HIV replication, we decreased CD63 expression using CD63-specific short interfering RNAs (siRNA), and showed inhibition of HIV replication in macrophages. Surprisingly, pretreatment with CD63 siRNA not only silenced CD63 expression by 90%, but also inhibited HIV-1 replication in a cultured cell line (U373-MAGI) which had been previously shown to be insensitive to CD63 monoclonal antibody inhibition. Although the anti-CD63 antibody was previously shown to inhibit early HIV infection events only in macrophages, we now show a potential role for CD63 in later HIV replication events in macrophages and cell lines. Further delineation of the role of CD63 in HIV replication may lead to development of novel therapeutic compounds.
Insights
CD63 protein is crucial for human immunodeficiency virus (HIV) replication in macrophages and cell lines. Inhibiting CD63 expression significantly reduces HIV replication, suggesting new therapeutic targets.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Human immunodeficiency virus (HIV) entry requires CD4 and chemokine coreceptors (CCR5/CXCR4).
- Additional cellular factors influence HIV replication.
- Previous studies indicated CD63's role in early HIV infection in macrophages.
Purpose of the Study:
- To confirm CD63's requirement in HIV replication.
- To investigate CD63's role in HIV replication in macrophages and cell lines.
- To explore CD63 as a potential therapeutic target for HIV.
Main Methods:
- Utilized CD63-specific short interfering RNAs (siRNA) to decrease CD63 expression.
- Assessed HIV replication inhibition in macrophages and U373-MAGI cell lines.
- Compared siRNA effects with previous anti-CD63 antibody inhibition data.
Main Results:
- CD63 siRNA significantly inhibited HIV replication in macrophages.
- CD63 siRNA also inhibited HIV-1 replication in U373-MAGI cells, which were previously insensitive to antibody inhibition.
- CD63 silencing achieved approximately 90% reduction in CD63 expression.
Conclusions:
- CD63 plays a significant role in HIV replication, extending beyond early events in macrophages.
- CD63 is implicated in later stages of HIV replication in both macrophages and cultured cell lines.
- Targeting CD63 may offer a novel therapeutic strategy for HIV infection.
